What is the price target for IR stock?
25 analysts have analysed IR and the average price target is 102.24 USD. This implies a price increase of 21.98% is expected in the next year compared to the current price of 83.81.
NYSE:IR • US45687V1061
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INGERSOLL-RAND INC (IR).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-14 | Stifel | Maintains | Hold -> Hold |
| 2026-04-13 | Citigroup | Maintains | Buy -> Buy |
| 2026-04-01 | Barclays | Maintains | Overweight -> Overweight |
| 2026-04-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-23 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-17 | Stifel | Maintains | Hold -> Hold |
| 2026-02-17 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-23 | Stifel | Maintains | Hold -> Hold |
| 2026-01-12 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-16 | Stifel | Maintains | Hold -> Hold |
| 2025-12-08 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-03 | Baird | Maintains | Outperform -> Outperform |
| 2025-11-03 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-20 | Stifel | Maintains | Hold -> Hold |
| 2025-10-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-04 | Stifel | Maintains | Hold -> Hold |
| 2025-08-04 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-04 | Baird | Maintains | Outperform -> Outperform |
| 2025-07-21 | Stifel | Maintains | Hold -> Hold |
| 2025-07-14 | Citigroup | Maintains | Buy -> Buy |
| 2025-07-09 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.876B 16.22% | 7.235B 5.22% | 7.651B 5.75% | 8.194B 7.10% | 8.586B 4.78% | 9.042B 5.31% | 10.048B 11.13% | 11.491B 14.36% | |
| EBITDA YoY % growth | 1.701B 29.60% | 1.936B 13.86% | 2.015B 4.08% | 2.239B 11.10% | 2.403B 7.32% | 2.585B 7.57% | 2.979B 15.24% | 3.415B 14.64% | |
| EBIT YoY % growth | 1.242B 41.18% | 1.454B 17.14% | 1.51B 3.80% | 1.975B 30.84% | 2.102B 6.43% | 2.268B 7.90% | 2.251B -0.75% | N/A | |
| Operating Margin | 18.06% | 20.10% | 19.73% | 24.10% | 24.48% | 25.08% | 22.40% | N/A | |
| EPS YoY % growth | 2.96 24.89% | 3.29 11.15% | 3.34 1.52% | 3.64 8.94% | 4.01 10.24% | 4.42 10.25% | 5.24 18.43% | 6.40 22.12% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.76 5.92% | 0.88 10.51% | 0.94 9.52% | 1.04 8.00% | 0.82 8.05% | 0.95 7.18% | 1.02 7.90% | 1.12 7.62% |
| Revenue Q2Q % growth | 1.889B 10.03% | 2.03B 7.53% | 2.064B 5.58% | 2.202B 5.30% | 1.951B 3.28% | 2.097B 3.30% | 2.111B 2.28% | 2.265B 2.86% |
| EBITDA Q2Q % growth | 485.07M 9.15% | 548M -9.23% | 577.91M -24.31% | 625.05M -32.73% | 503.16M 3.73% | 569.59M 3.94% | 593.38M 2.68% | 652.3M 4.36% |
| EBIT Q2Q % growth | 407.79M 25.71% | 468.87M 29.09% | 498.02M 24.97% | 545.81M 28.91% | 469.06M 15.02% | 535.7M 14.25% | 559.39M 12.32% | 618.21M 13.26% |
All data in USD
25 analysts have analysed IR and the average price target is 102.24 USD. This implies a price increase of 21.98% is expected in the next year compared to the current price of 83.81.
INGERSOLL-RAND INC (IR) will report earnings on 2026-04-28, after the market close.
The consensus EPS estimate for the next earnings of INGERSOLL-RAND INC (IR) is 0.76 USD and the consensus revenue estimate is 1.89B USD.
The consensus rating for INGERSOLL-RAND INC (IR) is 76.8 / 100 . This indicates that analysts generally have a positive outlook on the stock.